Additionally, we discovered that high VSIG4 expression levels and reduced CD8A expression were associated with poor overall survival (OS) in patients (Figure 8C,D), suggesting that CD8A and VSIG4 may serve as valuable prognostic indicators for CRC patients. This evidence concerns the gene VSIG4 and colorectal carcinoma.